Home » Lianhuan Pharmaceutical: The net profit for the first half of 2021 is approximately 54.39 million yuan, an increase of 20.59% year-on-year

Lianhuan Pharmaceutical: The net profit for the first half of 2021 is approximately 54.39 million yuan, an increase of 20.59% year-on-year

by admin


  Lianhuan Pharmaceutical(SH 600513, closing price: 8.44 yuan) Semi-annual release on the evening of August 24PerformanceAccording to the report, in the first half of 2021Operating incomeApproximately 759 million yuan, an increase of 23.25% year-on-year; attributable to listed companiesShareholdersOfNet profitEarnings were about 54.39 million yuan, an increase of 20.59% year-on-year; basic earnings per share were 0.19 yuan, an increase of 18.75% year-on-year. The distribution plan is: the company does not distribute profit, and the capital reserve is converted to share capital.

According to the 2020 annual report,Lianhuan PharmaceuticalThe main business ofPharmaceutical manufacturing, Pharmaceutical circulation, and other industries accounted for 59.11%, 38.64%, and 0.92% of revenue respectively.

  Lianhuan PharmaceuticalThe chairman of the board is Wu Wenge, male, 54 years old, Han nationality, Chinese nationality, bachelor degree, engineer, graduated from Beijing Institute of Chemical Technology, university degree, engineer, successively served as technician and deputy director of the fifth workshop of Yangzhou Pharmaceutical Factory, and the fourth workshop of Yangzhou Pharmaceutical Factory Assistant Director, Director, Director of the Second Workshop of Yangzhou Pharmaceutical Co., Ltd., Assistant General Manager and Deputy General Manager of Yangzhou Pharmaceutical Co., Ltd. The general manager of Lianhuan Pharmaceutical is Qian Zhenhua, male, 50 years old, Chinese nationality, college degree, graduated from Yangzhou University School of Medicine, majoring in clinical medicine, and attending physician.

(Source: Daily Economic News)


Article source: Daily Economic News

Editor in charge: DF552

See also  Inflation in Mexico: Concerns Over Rising Prices in Lunch Shops and Restaurants

Original title: Lianhuan Pharmaceutical: The net profit for the first half of 2021 is approximately 54.39 million yuan, an increase of 20.59% year-on-year

Solemnly declare: The purpose of this information released by Oriental Fortune.com is to spread more information and has nothing to do with this stand.

Report

Share to WeChat Moments

Open WeChat,

Click “Discover” at the bottom

Use “Scan”

You can share the webpage to Moments

Scan the QR code to follow

Oriental Wealth Official Website WeChat

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy